Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris)
CA 2537161 C · Owner: Vendevia Group, Llc · Inventors: Ghochikyan, Anahit; Agadjanyan, Michael G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Polynucleotides encoding a nonfunctional mutant form of the Brother of Regulator of Imprinted Sites (BORIS) molecule nonfunctional mutated BORIS , protein, polypeptide or peptide and modified protein forms of BORIS are described. These molecules are used as a therapeutic vaccine against cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 25, 2004 and granted July 29, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 25, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 25, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.